SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
SocialPicks Community
Access Pharma (OTC: ACCP.OB): MuGard Launch Expected 1Q10
ACCP
|
|
|
Access Pharma (OTC: ACCP.OB) provided an update today on the status of the North American commercial launch for its FDA cleared treatment for oral mucositis, MuGard, which is expected to occur during 1Q10 in conjunction with the availability of initial product inventory by its liquid contract manufacturing partner, Accupac. In addition, Access signed an e-Marketing deal with iMedicor (OTC: VMCI.OB) in early October as a cost-efficient and highly targeted means of reaching over 200,000 oncologists in the U.S. market. <> The e-Marketing deal and pending domestic MuGar...
|
FDA Calendar November Stocks: Turkeys or a Happy Thanksgiving?
ACCP
|
|
|
<> <> On 7/15/09, Cadence Pharma (NASDAQ: CADX) announced that its New Drug Application (NDA) for Acetavance (intravenous acetaminophen), its investigational product candidate for the treatment of acute pain and fever in adults and children, has been accepted for filing by the FDA and designated for a priority (six-month) review. The FDA has issued a PDUFA action date for the NDA of 11/13/09 for a possible decision by the Agency. The Company's 505(b)(2) NDA for Acetavance includes data from one pivotal clinical trial for the treatment of acute pain in patients following orthopedic surgery and ...
|
Access Pharma (OTC: ACCP.OB): Clinical, Commercial MuGard Updates
ACCP
|
|
|
Access Pharma (OTC: ACCP.OB) provided an update this morning on the clinical and commercial status of MuGard, which has already been launched by its partner, SpePharm, in five European countries for the prevention and treatment of oral mucositis. SpePharm is currently collecting information from approximately 1,500-2,000 patients as part of a comprehensive set of post-marketing / seeding studies being conducted in the UK, Germany, and Italy. <o:p> </o:p> <o:p> </o:p> http://www.mikehavrx.com/2009/10/access-pharma-otc-accpob-cli... <o:p> </o:p> <> <> <o:p> ...
|
Access Pharma, iMedicor Sign e-Marketing Deal for MuGard
ACCP
|
|
|
Access Pharma (OTC: ACCP.OB) announced an e-Marketing deal today with iMedicor (OTC: VMCI.OB) for the commercial launch of MuGard through the latter’s targeted marketing / education Alerts System application through NaviNet, which is a secure network of over 700,000 healthcare providers and support staff. Over 200,000 oncology-related clinicians in the U.S. will be targeted with information on MuGard and the treatment of oral mucositis, with an expected commercial launch before year-end. <> <> <font> http://www.mikehavrx.com/2009/10/access-pharma-imedicor-sign-... </font>...
|
Access Pharma (OTC: ACCP.OB): MuGard, Pipeline Makes for Appealing Acquisition Possibilities
ACCP
|
|
|
Access Pharma (OTC: ACCP.OB) is an emerging bio-pharmaceutical company which is focusing on the development of a late-stage, diversified oncology pipeline in addition to a treatment called MuGard is cleared for marketing in the U.S., Europe, and other key global markets for a common side effect of some cancer treatments known as mucositis (painful sores in the mouth and GI mucosal lining). <o:p> </o:p> <o:p> </o:p> http://www.mikehavrx.com/2009/09/access-pharma-otc-accpob-mug... <o:p> </o:p> <o:p> </o:p> <> <> In addition, the Company is devel...
|
From the Blogosphere
Business Week’s Gene Marcial’s Stock Picks 7/14/08 Issue
|
|
|
<>Gene Marcial, Business Week’s Inside Wall Street columnist and stock market guru, recommended the following stocks in the 7/14/08 issue: 1. Mosaic (MOS) a. Producer of phosphate rock and potash; the prices of fertilizers, such as potash and phosphate, have exploded due to escalating global demand; and the floods in the Midwest and jump in corn plantings are further driving up fertilizer prices boosting Mosaic’s earnings. <>b. Mosaic is one of the best ways to play these favorable trends given its leadership in phosphate (No.1) and potash (No.2). And it could use its strong cash flow to initi...
|
Business Week???s Gene Marcial???s Stock Picks 7/14/08 Issue
|
|
|
Gene Marcial, Business Week’s Inside Wall Street columnist and stock market guru, recommended the following stocks in the 7/14/08 issue: 1. Mosaic (MOS) a. Producer of phosphate rock and potash; the prices of fertilizers, such as potash and phosphate, have exploded due to escalating global demand; and the floods in the Midwest and jump in corn plantings are further driving up fertilizer prices boosting Mosaic’s earnings. <>b. Mosaic is one of the best ways to play these favorable trends given its leadership in phosphate (No.1) and potash (No.2). And it could use its strong cash flow to initi...
|
Business Week???s Gene Marcial???s Stock Picks 7/14/08 Issue
|
|
|
Gene Marcial, Business Week’s Inside Wall Street columnist and stock market guru, recommended the following stocks in the 7/14/08 issue: 1. Mosaic (MOS) a. Producer of phosphate rock and potash; the prices of fertilizers, such as potash and phosphate, have exploded due to escalating global demand; and the floods in the Midwest and jump in corn plantings are further driving up fertilizer prices boosting Mosaic’s earnings. <>b. Mosaic is one of the best ways to play these favorable trends given its leadership in phosphate (No.1) and potash (No.2). And it could use its strong cash flow to initi...
|
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
| StreetInsider.com on ACCP |
Visit streetinsider.com
More Resources
|
About Access Pharmaceuticals Inc.
- Answers.com
